Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Minaprine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Minaprine | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Minaprine | hsa00190 | Oxidative phosphorylation | 4.38E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Minaprine | hsa00230 | Purine metabolism | 4.93E-02 | 1 | P21589 | NT5E | More | | Minaprine | hsa00240 | Pyrimidine metabolism | 1.81E-02 | 1 | P21589 | NT5E | More | | Minaprine | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Minaprine | hsa00564 | Glycerophospholipid metabolism | 2.49E-03 | 4 | Q9Y259, P23743, P49619, Q3LIE5 | CHKB, DGKA, DGKG, ADPRM | More | | Minaprine | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.87E-03 | 3 | P06865, O15466, Q9H4F1 | HEXA, ST8SIA5, ST6GALNAC4 | More | | Minaprine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.34E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Minaprine | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Minaprine | hsa00760 | Nicotinate and nicotinamide metabolism | 9.09E-03 | 1 | P21589 | NT5E | More | | Minaprine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Minaprine | hsa00790 | Folate biosynthesis | 1.04E-02 | 3 | Q92820, P05186, P42330 | GGH, ALPL, AKR1C3 | More | | Minaprine | hsa00830 | Retinol metabolism | 3.49E-02 | 1 | P00325 | ADH1B | More | | Minaprine | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Minaprine | hsa00983 | Drug metabolism - other enzymes | 4.16E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Minaprine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Minaprine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | | Minaprine | hsa01240 | Biosynthesis of cofactors | 2.52E-02 | 2 | Q9BQB6, P14550 | VKORC1, AKR1A1 | More | | Minaprine | hsa01523 | Antifolate resistance | 3.99E-03 | 4 | P41440, Q92820, P04818, P01375 | SLC19A1, GGH, TYMS, TNF | More | | Minaprine | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Minaprine | hsa03013 | RNA transport | 4.09E-02 | 9 | P52298, Q09161, O14893, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Minaprine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Minaprine | hsa03040 | Spliceosome | 1.06E-04 | 12 | Q14562, O43143, O60508, P08579, O75940, O75494, Q07955, Q01130, Q13243, P11142, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, SMNDC1, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, PPIH, ASCC3L1 | More | | Minaprine | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Minaprine | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | | Minaprine | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Minaprine | hsa03460 | Fanconi anemia pathway | 2.71E-02 | 1 | O94782 | USP1 | More | | Minaprine | hsa04014 | Ras signaling pathway | 6.21E-03 | 8 | P20827, P49767, P17252, Q15311, P0DP23, P62873, P19174, P17612 | EFNA1, VEGFC, PRKCA, RALBP1, CALM1, GNB1, PLCG1, PRKACA | More | | Minaprine | hsa04015 | Rap1 signaling pathway | 2.98E-02 | 6 | P20827, P49767, P11215, P0DP23, P17252, P19174 | EFNA1, VEGFC, ITGAM, CALM1, PRKCA, PLCG1 | More | | Minaprine | hsa04020 | Calcium signaling pathway | 4.81E-02 | 5 | P27987, P17252, P19174, P0DP23, P49767 | ITPKB, PRKCA, PLCG1, CALM1, VEGFC | More | | Minaprine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.29E-02 | 6 | P09341, P25024, P25025, P47992, Q9UBD3, P01375 | CXCL1, CXCR1, CXCR2, XCL1, XCL2, TNF | More | | Minaprine | hsa04064 | NF-kappa B signaling pathway | 3.26E-05 | 14 | P10415, Q13489, P25963, P51617, O00463, P01375, P29965, Q04759, Q9UDY8, Q13077, Q16548, Q8WV28, Q13315, P24522 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, TNF, CD40LG, PRKCQ, MALT1, TRAF1, BCL2A1, BLNK, ATM, GADD45A | More | | Minaprine | hsa04070 | Phosphatidylinositol signaling system | 1.01E-04 | 7 | P19174, P0DP23, Q14643, P23743, P49619, P27987, P17252 | PLCG1, CALM1, ITPR1, DGKA, DGKG, ITPKB, PRKCA | More | | Minaprine | hsa04071 | Sphingolipid signaling pathway | 5.14E-05 | 7 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Minaprine | hsa04080 | Neuroactive ligand-receptor interaction | 3.60E-05 | 11 | P08311, P28472, Q15722, P21453, Q9H228, P43657, O00398, P21462, P21730, P07550, P35318 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, FPR1, C5AR1, ADRB2, ADM | More | | Minaprine | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Minaprine | hsa04114 | Oocyte meiosis | 2.15E-02 | 3 | P0DP23, P17612, Q13362 | CALM1, PRKACA, PPP2R5C | More | | Minaprine | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Minaprine | hsa04120 | Ubiquitin mediated proteolysis | 1.08E-03 | 6 | Q9UBT2, Q14145, Q13042, P62837, Q15751, Q14669 | SAE2, KEAP1, CDC16, UBE2D2, HERC1, TRIP12 | More | | Minaprine | hsa04144 | Endocytosis | 4.07E-03 | 5 | Q9H444, O75351, P42566, Q15438, Q14161 | CHMP4B, VPS4B, EPS15, PSCD1, GIT2 | More | | Minaprine | hsa04145 | Phagosome | 1.78E-04 | 9 | Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Minaprine | hsa04151 | PI3K-Akt signaling pathway | 4.50E-02 | 9 | P25116, P49767, Q13362, P62873, P16144, O60603, P01568, P10415, P17252 | F2R, VEGFC, PPP2R5C, GNB1, ITGB4, TLR2, IFNA21, BCL2, PRKCA | More | | Minaprine | hsa04210 | Apoptosis | 1.52E-02 | 9 | Q13315, P10415, Q13489, P25963, P01375, P24522, Q16548, Q13077, Q14643 | ATM, BCL2, BIRC3, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, ITPR1 | More | | Minaprine | hsa04217 | Necroptosis | 1.73E-05 | 15 | P01375, P01568, P23458, P48023, Q13489, Q9NQC7, P42224, Q14765, Q6FI13, Q99878, P10415, Q9H444, O43633, O75351, Q08752 | TNF, IFNA21, JAK1, FASLG, BIRC3, CYLD, STAT1, STAT4, H2AC18; H2AC19, H2AC14, BCL2, CHMP4B, CHMP2A, VPS4B, PPID | More | | Minaprine | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | | Minaprine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.96E-04 | 9 | P09493, P07550, P17612, P22694, P18848, Q13362, P0DP23, P17252, P10415 | TPM1, ADRB2, PRKACA, PRKACB, ATF4, PPP2R5C, CALM1, PRKCA, BCL2 | More | | Minaprine | hsa04270 | Vascular smooth muscle contraction | 3.82E-02 | 5 | P24723, Q04759, Q14643, P22694, P35318 | PRKCH, PRKCQ, ITPR1, PRKACB, ADM | More | | Minaprine | hsa04360 | Axon guidance | 1.53E-02 | 5 | P16333, P20827, O95631, P17252, P19174 | NCK1, EFNA1, NTN1, PRKCA, PLCG1 | More | | Minaprine | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Minaprine | hsa04540 | Gap junction | 1.29E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Minaprine | hsa04610 | Complement and coagulation cascades | 2.78E-03 | 1 | P0C0L4 | C4A | More | | Minaprine | hsa04612 | Antigen processing and presentation | 6.89E-05 | 8 | P13765, Q14953, P26715, P26717, Q07444, Q13241, P01732, P01375 | HLA-DOB, KIR2DS5, KLRC1, KLRC2, KLRC3, KLRD1, CD8A, TNF | More | | Minaprine | hsa04613 | Neutrophil extracellular trap formation | 3.86E-06 | 22 | P19174, P17252, P11215, O60603, P05164, P08246, Q9UM07, P04908, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, P49913, P21730, P21462, O43315, Q16539 | PLCG1, PRKCA, ITGAM, TLR2, MPO, ELA2, PADI4, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1, AQP9, MAPK14 | More | | Minaprine | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Minaprine | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Minaprine | hsa04640 | Hematopoietic cell lineage | 1.73E-03 | 12 | P13612, P21926, P27930, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375 | ITGA4, CD9, IL1R2, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF | More | | Minaprine | hsa04650 | Natural killer cell mediated cytotoxicity | 1.40E-06 | 11 | P01375, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, Q07444, Q14953, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC3, KIR2DS5, KLRC1 | More | | Minaprine | hsa04657 | IL-17 signaling pathway | 5.70E-05 | 12 | P25963, P08238, O00463, Q07955, Q16539, P49841, P19875, P14780, P04141, P80188, P01375, P06702 | NFKBIA, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL2, MMP9, CSF2, LCN2, TNF, S100A9 | More | | Minaprine | hsa04658 | Th1 and Th2 cell differentiation | 1.45E-05 | 14 | P25963, Q04759, P20963, P09693, P19174, P06239, P42224, Q14765, P23771, Q9UL17, P14784, Q9UM47, P13765, Q13761 | NFKBIA, PRKCQ, CD247, CD3G, PLCG1, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, NOTCH3, HLA-DOB, RUNX3 | More | | Minaprine | hsa04659 | Th17 cell differentiation | 2.92E-03 | 12 | P25963, Q04759, P19174, P06239, P42224, P14784, P13765, Q9UL17, P23771, P08238, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, TBX21, GATA3, HSP90AB1, CD3G, CD247 | More | | Minaprine | hsa04660 | T cell receptor signaling pathway | 1.63E-03 | 12 | P01375, P25963, Q9UDY8, Q04759, P10747, O95267, Q08881, P20963, P09693, P01732, Q13191, P06239 | TNF, NFKBIA, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, LCK | More | | Minaprine | hsa04662 | B cell receptor signaling pathway | 1.49E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Minaprine | hsa04664 | Fc epsilon RI signaling pathway | 2.20E-03 | 6 | P01375, Q16539, P42338, Q9UQC2, P07948, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, ALOX5 | More | | Minaprine | hsa04668 | TNF signaling pathway | 2.13E-04 | 10 | P01375, O00463, Q13489, Q16539, P25963, P18848, P19875, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, MAPK14, NFKBIA, ATF4, CXCL2, BCL3, TRAF1, MMP9 | More | | Minaprine | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Minaprine | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Minaprine | hsa04713 | Circadian entrainment | 3.30E-03 | 5 | P0DP23, P17252, P62873, Q14643, P17612 | CALM1, PRKCA, GNB1, ITPR1, PRKACA | More | | Minaprine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Minaprine | hsa04720 | Long-term potentiation | 6.75E-03 | 4 | P17252, P0DP23, P17612, Q14643 | PRKCA, CALM1, PRKACA, ITPR1 | More | | Minaprine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Minaprine | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Minaprine | hsa04724 | Glutamatergic synapse | 5.94E-03 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Minaprine | hsa04725 | Cholinergic synapse | 1.90E-03 | 7 | Q14643, P17252, P62873, P63218, P50151, P42338, P10415 | ITPR1, PRKCA, GNB1, GNG5, GNG10, PIK3CB, BCL2 | More | | Minaprine | hsa04727 | GABAergic synapse | 1.63E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Minaprine | hsa04728 | Dopaminergic synapse | 2.36E-03 | 6 | P17612, Q14643, P17252, P62873, Q13362, P0DP23 | PRKACA, ITPR1, PRKCA, GNB1, PPP2R5C, CALM1 | More | | Minaprine | hsa04740 | Olfactory transduction | 4.53E-04 | 3 | Q9H255, P0DP23, P17612 | OR51E2, CALM1, PRKACA | More | | Minaprine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Minaprine | hsa04744 | Phototransduction | 9.81E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Minaprine | hsa04910 | Insulin signaling pathway | 3.62E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | | Minaprine | hsa04912 | GnRH signaling pathway | 3.89E-02 | 3 | P17252, Q14643, P0DP23 | PRKCA, ITPR1, CALM1 | More | | Minaprine | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Minaprine | hsa04916 | Melanogenesis | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | | Minaprine | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Minaprine | hsa04921 | Oxytocin signaling pathway | 1.84E-02 | 3 | P0DP23, P17612, Q96RR4 | CALM1, PRKACA, CAMKK2 | More | | Minaprine | hsa04922 | Glucagon signaling pathway | 3.47E-02 | 4 | Q12778, Q13370, P0DP23, Q14643 | FOXO1, PDE3B, CALM1, ITPR1 | More | | Minaprine | hsa04924 | Renin secretion | 2.29E-06 | 6 | P17612, P22694, P07550, Q14643, Q13370, P0DP23 | PRKACA, PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Minaprine | hsa04926 | Relaxin signaling pathway | 3.93E-04 | 9 | P42338, P63218, P50151, P18848, P22694, P49767, P14780, P30679, P49407 | PIK3CB, GNG5, GNG10, ATF4, PRKACB, VEGFC, MMP9, GNA15, ARRB1 | More | | Minaprine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Minaprine | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Minaprine | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | | Minaprine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.27E-02 | 5 | P42224, P10415, Q12778, P49767, P17252 | STAT1, BCL2, FOXO1, VEGFC, PRKCA | More | | Minaprine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Minaprine | hsa04966 | Collecting duct acid secretion | 8.41E-04 | 4 | Q13488, P02730, P00918, Q9Y666 | TCIRG1, SLC4A1, CA2, SLC12A7 | More | | Minaprine | hsa04970 | Salivary secretion | 2.49E-04 | 7 | P07550, P17612, P22694, Q14643, P17252, P0DP23, P49913 | ADRB2, PRKACA, PRKACB, ITPR1, PRKCA, CALM1, CAMP | More | | Minaprine | hsa04971 | Gastric acid secretion | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | | Minaprine | hsa04976 | Bile secretion | 1.74E-03 | 4 | O43315, P17612, P08183, Q14032 | AQP9, PRKACA, ABCB1, BAAT | More | | Minaprine | hsa05010 | Alzheimer disease | 3.55E-02 | 7 | Q16718, O14521, Q14643, P0DP23, Q13509, P68371, Q08752 | NDUFA5, SDHD, ITPR1, CALM1, TUBB3, TUBB2C, PPID | More | | Minaprine | hsa05012 | Parkinson disease | 2.25E-02 | 6 | Q16718, O14521, Q14643, P0DP23, Q13509, P68371 | NDUFA5, SDHD, ITPR1, CALM1, TUBB3, TUBB2C | More | | Minaprine | hsa05020 | Prion disease | 1.31E-03 | 9 | Q16718, O14521, Q14643, Q13509, P68371, P49841, P14598, Q15080, Q16539 | NDUFA5, SDHD, ITPR1, TUBB3, TUBB2C, GSK3B, NCF1, NCF4, MAPK14 | More | | Minaprine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.00E-04 | 12 | Q14643, Q13509, P68371, P49841, P10415, Q16718, O14521, Q13561, P17252, Q16539, Q08752, P0DP23 | ITPR1, TUBB3, TUBB2C, GSK3B, BCL2, NDUFA5, SDHD, DCTN2, PRKCA, MAPK14, PPID, CALM1 | More | | Minaprine | hsa05031 | Amphetamine addiction | 3.10E-03 | 5 | P0DP23, P17612, P22694, P18848, Q13547 | CALM1, PRKACA, PRKACB, ATF4, HDAC1 | More | | Minaprine | hsa05034 | Alcoholism | 1.48E-03 | 7 | P17612, P0DP23, Q96RR4, P62873, Q93077, P62807, O60814 | PRKACA, CALM1, CAMKK2, GNB1, HIST1H2AC, HIST1H2BC, H2BC12 | More | | Minaprine | hsa05110 | Vibrio cholerae infection | 1.51E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Minaprine | hsa05131 | Shigellosis | 2.65E-03 | 14 | P01375, P25963, O00463, P68431, Q04759, Q9UDY8, Q9H1Y0, Q14247, Q14643, Q12778, Q13315, P10415, Q08752, Q96A32 | TNF, NFKBIA, TRAF5, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCQ, MALT1, ATG5, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID, MYLPF | More | | Minaprine | hsa05132 | Salmonella infection | 1.36E-03 | 12 | P51617, P25963, P01375, Q9UJU2, Q13489, P10415, Q96A32, O60603, Q9BQS8, Q13561, Q13509, P68371 | IRAK1, NFKBIA, TNF, LEF1, BIRC3, BCL2, MYLPF, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Minaprine | hsa05133 | Pertussis | 4.94E-02 | 1 | P0C0L4 | C4A | More | | Minaprine | hsa05140 | Leishmaniasis | 4.14E-06 | 10 | P14598, P11215, P42224, P13765, O60603, P25963, P01375, P29350, P51617, Q15080 | NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, IRAK1, NCF4 | More | | Minaprine | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Minaprine | hsa05144 | Malaria | 1.91E-02 | 3 | P01375, P35443, P26718 | TNF, THBS4, KLRK1 | More | | Minaprine | hsa05145 | Toxoplasmosis | 1.19E-03 | 9 | P51617, P25963, P01375, P10415, Q13489, P42224, P13765, O60603, P29965 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Minaprine | hsa05146 | Amoebiasis | 4.49E-04 | 9 | P09341, P19875, P27930, P01375, P05089, P30679, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R2, TNF, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Minaprine | hsa05152 | Tuberculosis | 1.21E-04 | 12 | Q13488, P0DP23, P42224, P48382, O60603, P01375, P10415, P13765, P01568, P49913, Q9UDY8, P51617 | TCIRG1, CALM1, STAT1, RFX5, TLR2, TNF, BCL2, HLA-DOB, IFNA21, CAMP, MALT1, IRAK1 | More | | Minaprine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Minaprine | hsa05161 | Hepatitis B | 2.33E-02 | 8 | P17252, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | | Minaprine | hsa05163 | Human cytomegalovirus infection | 2.80E-02 | 6 | P01375, P49841, P14778, P25025, Q16539, O00463 | TNF, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | | Minaprine | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Minaprine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 5.56E-03 | 9 | P01568, P42224, P25963, P62873, P19174, Q14643, P04141, P0DP23, Q9UJU2 | IFNA21, STAT1, NFKBIA, GNB1, PLCG1, ITPR1, CSF2, CALM1, LEF1 | More | | Minaprine | hsa05168 | Herpes simplex virus 1 infection | 4.39E-02 | 9 | P25963, P42224, Q07955, Q01130, Q13243, Q13398, Q03923, O75820, Q9UDV6 | NFKBIA, STAT1, SFRS1, SFRS2, SFRS5, ZNF211, ZNF85, ZNF189, ZNF212 | More | | Minaprine | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Minaprine | hsa05170 | Human immunodeficiency virus 1 infection | 1.80E-05 | 16 | P62873, P0DP23, P01375, P17252, O00463, Q14643, P01568, P51617, P25963, O60603, Q13315, O95067, P10415, Q13619, Q93034, Q9Y6Q5 | GNB1, CALM1, TNF, PRKCA, TRAF5, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, CCNB2, BCL2, CUL4A, CUL5, AP1M2 | More | | Minaprine | hsa05200 | Pathways in cancer | 6.46E-03 | 19 | P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P14923, P10415, Q13489, P49767, Q12778, P25116, P62873, Q9UM47, O75293, P0DP23, P01568, P14784 | HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, JUP, BCL2, BIRC3, VEGFC, FOXO1, F2R, GNB1, NOTCH3, GADD45B, CALM1, IFNA21, IL2RB | More | | Minaprine | hsa05202 | Transcriptional misregulation in cancer | 1.84E-05 | 18 | Q12778, Q15532, Q13315, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, Q13547, P12980, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | | Minaprine | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Minaprine | hsa05206 | MicroRNAs in cancer | 4.24E-02 | 6 | P30304, P09493, Q9UM47, P20827, P17252, P19174 | CDC25A, TPM1, NOTCH3, EFNA1, PRKCA, PLCG1 | More | | Minaprine | hsa05212 | Pancreatic cancer | 2.87E-02 | 2 | Q15311, P23458 | RALBP1, JAK1 | More | | Minaprine | hsa05214 | Glioma | 7.66E-03 | 4 | P0DP23, P17252, P19174, O75293 | CALM1, PRKCA, PLCG1, GADD45B | More | | Minaprine | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | | Minaprine | hsa05218 | Melanoma | 1.07E-02 | 3 | P09619, Q9GZP0, Q02750 | PDGFRB, PDGFD, MAP2K1 | More | | Minaprine | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Minaprine | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | | Minaprine | hsa05231 | Choline metabolism in cancer | 4.84E-05 | 9 | Q02750, P09619, Q9GZP0, O15245, Q9Y259, P19174, P23743, P49619, P17252 | MAP2K1, PDGFRB, PDGFD, SLC22A1, CHKB, PLCG1, DGKA, DGKG, PRKCA | More | | Minaprine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.09E-02 | 4 | P07766, P06239, Q9HC35, P01730 | CD3E, LCK, EML4, CD4 | More | | Minaprine | hsa05310 | Asthma | 1.22E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Minaprine | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Minaprine | hsa05321 | Inflammatory bowel disease | 1.07E-05 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Minaprine | hsa05322 | Systemic lupus erythematosus | 7.03E-05 | 13 | O75015, P08246, P08311, P09871, P01375, P10747, P13765, P29965, Q6FI13, Q16778, P68431, P12814, P05455 | FCGR3B, ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST2H2BE, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1, SSB | More | | Minaprine | hsa05323 | Rheumatoid arthritis | 1.29E-02 | 4 | P13765, Q13488, P10747, O60603 | HLA-DOB, TCIRG1, CD28, TLR2 | More | | Minaprine | hsa05330 | Allograft rejection | 1.04E-03 | 5 | P13765, P29965, P48023, P10747, P01375 | HLA-DOB, CD40LG, FASLG, CD28, TNF | More | | Minaprine | hsa05332 | Graft-versus-host disease | 8.53E-07 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Minaprine | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | | Minaprine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 3.10E-02 | 3 | Q8IZS8, P54284, P13612 | CACNA2D3, CACNB3, ITGA4 | More | | Minaprine | hsa05414 | Dilated cardiomyopathy | 2.11E-02 | 4 | Q8IZS8, P54284, P13612, P26678 | CACNA2D3, CACNB3, ITGA4, PLN | More | | Minaprine | hsa05415 | Diabetic cardiomyopathy | 1.58E-03 | 7 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B | More | | Minaprine | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Minaprine | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |